Trial document




drksid header

  DRKS00014230

Trial Description

start of 1:1-Block title

Title

Tablet-based computer-assisted data collection of functional aspects and quality of life by patients with head and neck tumors without and with direct feedback to the attending physician in a prospective controlled care study in the Department of Otorhinolaryngology, Head and Neck Surgery, University Clinic of Schleswig-Holstein Campus Lübeck

end of 1:1-Block title
start of 1:1-Block acronym

Trial Acronym

TaBeL

end of 1:1-Block acronym
start of 1:1-Block url

URL of the Trial

[---]*

end of 1:1-Block url
start of 1:1-Block public summary

Brief Summary in Lay Language

Patients with head and neck cancer often are not able to express themselves in a reasonable amount of time, so important information can be lost. If doctors already have a digital submission of significant patient issues, the resulting measures are more likely to follow and their documentation will be faster, making it easier to analyse therapies. The study aims to assess functioning, symptom burden, quality of life and survival as a function of tumor stage and therapy using interactive systems without or with feedback from patients in the routine care of patients with head and neck cancer. The question is whether there are differences between the patients with and without intervention regarding the digital feedback of the data of the patient survey to the physician 15 months after completion of the radiotherapy with regard to self-assessed health status, quality of life, pain and discomfort.

end of 1:1-Block public summary
start of 1:1-Block scientific synopsis

Brief Summary in Scientific Language

Functional impairments in head and neck tumors have so far been inadequately standardised in everyday clinical practice and considered in the context of general burden of symptom, survival and therapy as well as quality of life or used for direct care. The identification of risk factors in the course of treatment is insufficiently clarified, especially in follow-up depending on tumor stage and therapy.

Patients with head and neck cancers are often unable to adequately articulate in a timely manner so that they do not necessarily communicate relevant information. If physicians already have a digital presentation of significant patient problems, the resulting measures are more likely to follow and their documentation faster, which also makes it easier to analyse individual and collective treatment pathways.

New technical and design options for spatially flexible and mobile tablet-based data collection, task-oriented and immediate multimedia processing and the use of this information for routine care have hardly been established in this context. Experience with computer-assisted quality of life measurements indicates benefits for patients and physicians.

Since even the few known systems would have to be elaborately adapted and completed, local experts are developing or integrating interactive multimedia systems with user-friendly user interfaces. These are intended on the one hand to enable the data input by patients on a tablet PC, on the other hand, the multimedia data processing and the meaningful, fast and secure to be recorded representation of this data immediately for the doctor consultation.

A prospective nonrandomised controlled monocentric care study is being conducted in patients with head and neck tumors in the waiting group design. To evaluate the effects of including digital patient and physician information in therapy, a bipartite approach is planned (Phase 1 + 2). In the first phase of the project, the implementation of the digital patient survey and doctor checklist will be carried out with standardised tools for self- and external assessment. The data is encrypted, transferred to the study database and stored. The treatment is as usual. In the second phase of the project, individual results of the patient survey are displayed to the attending physician in a multimedia format so that they are immediately available for patient care and can be used for decision-making support. The digitally documented data on performance, results of the examination, abnormalities, side effects of the therapy (according to CTCAE) and resulting measures are also processed by multimedia. Time trends are displayed and defined values ​​are stored visually, whereby standard deviations become visible.

It examines the question of whether between patients with standardised digital survey and use
Patient Reported Outcomes (PROs), general burden of symptom, functional ability, therapy and survival significant differences to patients without use of these digital data 15 months after completion of radiotherapy.

end of 1:1-Block scientific synopsis
start of 1:1-Block organizational data

Organizational Data

  •   DRKS00014230
  •   2018/03/07
  •   [---]*
  •   yes
  •   Approved
  •   17-373, Ethik-Kommission Universität zu Lübeck Medizinische Fakultät des Universitätsklinikums Schleswig-Holstein
end of 1:1-Block organizational data
start of 1:n-Block secondary IDs

Secondary IDs

  • [---]*
end of 1:n-Block secondary IDs
start of 1:N-Block indications

Health Condition or Problem studied

  •   C01 -  Malignant neoplasm of base of tongue
  •   C02 -  Malignant neoplasm of other and unspecified parts of tongue
  •   C03 -  Malignant neoplasm of gum
  •   C04 -  Malignant neoplasm of floor of mouth
  •   C05 -  Malignant neoplasm of palate
  •   C06 -  Malignant neoplasm of other and unspecified parts of mouth
  •   C07 -  Malignant neoplasm of parotid gland
  •   C08 -  Malignant neoplasm of other and unspecified major salivary glands
  •   C09 -  Malignant neoplasm of tonsil
  •   C10 -  Malignant neoplasm of oropharynx
  •   C12 -  Malignant neoplasm of piriform sinus
  •   C13 -  Malignant neoplasm of hypopharynx
  •   C30 -  Malignant neoplasm of nasal cavity and middle ear
  •   C31 -  Malignant neoplasm of accessory sinuses
  •   C32 -  Malignant neoplasm of larynx
  •   comorbidity
  •   quality of life
  •   burden of symptoms
  •   functional impairment
  •   adverse events according to the Common Terminology Criteria for Adverse Events (CTCAE v4)
end of 1:N-Block indications
start of 1:N-Block interventions

Interventions/Observational Groups

  •   Patients with primary diagnosis of head and neck tumors, who participating on a tablet-based data colletction (PROs) and whose physician reported to a digital physician checklist on general burden of symptom, health, therapy, and side effects . The treatment is as usual. The information serves as a control and is not available to the attending physician.

  •   Patients with primary diagnosis of head and neck tumors, who participating on a tablet-based data colletction (PROs) and whose physician reported to a digital physician checklist on general burden of symptom, health, therapy, and side effects . The data are processed in a multimedia format and are available to the attending physician for the purpose of providing decision support for the treatment. In doing so, temporal trends and abnormal results are visually highlighted.
end of 1:N-Block interventions
start of 1:1-Block design

Characteristics

  •   Interventional
  •   [---]*
  •   Non-randomized controlled trial
  •   Open (masking not used)
  •   [---]*
  •   Active control (effective treament of control group)
  •   Other
  •   Other
  •   N/A
  •   N/A
end of 1:1-Block design
start of 1:1-Block primary endpoint

Primary Outcome

EORTC QLQ-C30 (subscale fatigue, general health and quality of life, gastrointestinal side effects);

Data collection: using a tablet-based patient survey and digital doctor checklist;

time of measurement: before the start of therapy, after completion of the primary therapy, directly after radiotherapy, 3, 6, 9 12 and 15 months after irradiation;

The study aims to assess the functional ability, symptom burden and quality of life as a function of tumor stage and therapy by means of interactive systems in the routine practical care of patients with head and neck cancer.

end of 1:1-Block primary endpoint
start of 1:1-Block secondary endpoint

Secondary Outcome

Pain, GAD-2, PHQ-9, social score, rehabilitation needs, EAT-10, survival

end of 1:1-Block secondary endpoint
start of 1:n-Block recruitment countries

Countries of Recruitment

  •   Germany
end of 1:n-Block recruitment countries
start of 1:n-Block recruitment locations

Locations of Recruitment

  • University Medical Center 
end of 1:n-Block recruitment locations
start of 1:1-Block recruitment

Recruitment

  •   Actual
  •   2018/05/07
  •   320
  •   Monocenter trial
  •   National
end of 1:1-Block recruitment
start of 1:1-Block inclusion criteria

Inclusion Criteria

  •   Both, male and female
  •   18   Years
  •   no maximum age
end of 1:1-Block inclusion criteria
start of 1:1-Block inclusion criteria add

Additional Inclusion Criteria

Patients with diagnosis ICD-10 C01-C10, C12-13 or C30-C32; sufficient knowledge of German in spoken and written

end of 1:1-Block inclusion criteria add
start of 1:1-Block exclusion criteria

Exclusion Criteria

non-existent consent, emergency patients, patients younger than 18 years of study, patients with intellectual disability (ICD-10 F70-F79), dementia, Alzheimer's disease

end of 1:1-Block exclusion criteria
start of 1:n-Block addresses

Addresses

  • start of 1:1-Block address primary-sponsor
    • Universität zu Lübeck
    • Ratzeburger Allee 160
    • 23562  Lübeck
    • Germany
    end of 1:1-Block address primary-sponsor
    start of 1:1-Block address contact primary-sponsor
    •   [---]*
    •   [---]*
    •   [---]*
    •   [---]*
    end of 1:1-Block address contact primary-sponsor
  • start of 1:1-Block address scientific-contact
    • Universität zu Lübeck
    • Ms.  Elke  Peters 
    • Ratzeburger Allee 160
    • 23562  Lübeck
    • Germany
    end of 1:1-Block address scientific-contact
    start of 1:1-Block address contact scientific-contact
    end of 1:1-Block address contact scientific-contact
  • start of 1:1-Block address public-contact
    • Universität zu Lübeck
    • Ms.  Elke  Peters 
    • Ratzeburger Allee 160
    • 23562  Lübeck
    • Germany
    end of 1:1-Block address public-contact
    start of 1:1-Block address contact public-contact
    end of 1:1-Block address contact public-contact
end of 1:n-Block addresses
start of 1:n-Block material support

Sources of Monetary or Material Support

  • start of 1:1-Block address materialSupport
    • Stiftung Deutsche Krebshilfe
    • 53113  Bonn
    • Germany
    end of 1:1-Block address materialSupport
    start of 1:1-Block address contact materialSupport
    •   +49228729900
    •   +492287299011
    •   [---]*
    •   [---]*
    end of 1:1-Block address contact materialSupport
  • start of 1:1-Block address otherSupport
    • Universität zu Lübeck
    • Ratzeburger Allee 160
    • 23562  Lübeck
    • Germany
    end of 1:1-Block address otherSupport
    start of 1:1-Block address contact otherSupport
    •   [---]*
    •   [---]*
    •   [---]*
    •   [---]*
    end of 1:1-Block address contact otherSupport
end of 1:n-Block material support
start of 1:1-Block state

Status

  •   Recruiting ongoing
  •   [---]*
end of 1:1-Block state
start of 1:n-Block publications

Trial Publications, Results and other Documents

  • [---]*
end of 1:n-Block publications
* This entry means the parameter is not applicable or has not been set.